dendritic cells

Latest Headlines

Latest Headlines

ASCO preview: What's the outlook for cancer vaccines?

The cancer vaccine field has seen its share of late-stage disappointments and outright flops, but a number of hopefuls are lining up to present new research backing their experimental shots at this year's upcoming American Society of Clinical Oncology Annual Meeting in Chicago.

New molecule could provide relief for autoimmune, inflammatory diseases

The discovery of a molecule that coaxes cells to self-destruct may provide a novel way to treat immune disorders and inflammation, according to a new study.

Investigators probe cancer vax effectiveness

A response between monocyte-derived dendritic cells and cancer has dealt a setback when it comes to fighting the disease with vaccines.

Labs, NIH zero in on painless vaccine technology

The Infectious Disease Research Institute and Medicago plan to remove the 'ouch' from vaccine administration. The pair is working on delivering virus-like particles through a device that uses pain-free microneedles.

New white blood cell variation is provocative cancer vaccine target

They exist. Researchers from Newcastle University in the U.K. and colleagues have spotted a new type of white blood cell that, in response to some kind of external source, can activate a killing immune response in the body.

HPV DNA vax should enter the clinic in 2013

Vaccibody's lead therapeutic DNA vaccine, developed for the treatment of precancerous changes in the cervix caused by human papillomavirus (HPV) infection, is expected to move into the clinic in late 2013 once funding is in place, the company CEO Ole Henrik Brekke told FierceVaccines  at BIO 2012.

Vaccine approach could trick immune system

Creating vaccines that bind to a damaged cell-recognition molecule called Clec9A could trick dendritic cells into thinking they have encountered a damaged cell and help to launch an immune response.

Key protein appears to kill off HIV food supply in certain cells

Today, we're one small but significant step closer to figuring out how to get certain cells to fight back against HIV infection. Specifically, scientists with the NYU Langone Medical Center and